EP0307523B1 - Flüssige Nahrungsmittel - Google Patents

Flüssige Nahrungsmittel Download PDF

Info

Publication number
EP0307523B1
EP0307523B1 EP87308205A EP87308205A EP0307523B1 EP 0307523 B1 EP0307523 B1 EP 0307523B1 EP 87308205 A EP87308205 A EP 87308205A EP 87308205 A EP87308205 A EP 87308205A EP 0307523 B1 EP0307523 B1 EP 0307523B1
Authority
EP
European Patent Office
Prior art keywords
fru
glc
gal
oligosaccharides
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
EP87308205A
Other languages
English (en)
French (fr)
Other versions
EP0307523A1 (de
Inventor
Tatsuhiko C/O Kabushiki Kaisha Yakult Honsha Kan
Yoichi Kabushiki Kaisha Yakult Honsha Kobayashi
Yoshiko Kabushiki Kaisha Yakult Honsha Sonoike
Tsuneo Kabushiki Kaisha Yakult Honsha Terashima
Masahiko Kabushiki Kaisha Yakult Honsha Mutai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yakult Honsha Co Ltd
Original Assignee
Yakult Honsha Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to JP61058134A priority Critical patent/JPS62220169A/ja
Priority to AU78155/87A priority patent/AU624065B2/en
Priority to US07/096,483 priority patent/US4859488A/en
Priority to CA000546865A priority patent/CA1324529C/en
Application filed by Yakult Honsha Co Ltd filed Critical Yakult Honsha Co Ltd
Priority to DE8787308205T priority patent/DE3785035T2/de
Priority to EP87308205A priority patent/EP0307523B1/de
Publication of EP0307523A1 publication Critical patent/EP0307523A1/de
Application granted granted Critical
Publication of EP0307523B1 publication Critical patent/EP0307523B1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/13—Fermented milk preparations; Treatment using microorganisms or enzymes using additives
    • A23C9/1307—Milk products or derivatives; Fruit or vegetable juices; Sugars, sugar alcohols, sweeteners; Oligosaccharides; Organic acids or salts thereof or acidifying agents; Flavours, dyes or pigments; Inert or aerosol gases; Carbonation methods
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
    • A23F5/00—Coffee; Coffee substitutes; Preparations thereof
    • A23F5/24—Extraction of coffee; Coffee extracts; Making instant coffee
    • A23F5/243—Liquid, semi-liquid or non-dried semi-solid coffee extract preparations; Coffee gels; Liquid coffee in solid capsules
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/125—Casei
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/51—Bifidobacterium

Definitions

  • This invention relates to a liquid food effective for improving constipation.
  • this invention relates to a liquid food effective for improving constipation, which being superior in taste, and pleasant to the palate.
  • This invention relates to providing a novel liquid food having superior taste and texture that is easy to ingest, and which in small amounts, can impart remarkable effects in improving constipation.
  • An example of a liquid food provided by the present invention comprises, as main components for improving constipation, Polydextrose R and raffinose family oligosaccharides which are made from soybean and are hard to digest and easy to ferment.
  • Another example of a liquid food provided by the present invention comprises, as main components for improving constipation, Polydextrose R and galactose series oligosaccharides which are made from lactose and are hard to digest and easy to ferment.
  • both Polydextrose R and oligosaccharides are completely water soluble, have no solid substance and have good texture. Although each component has an effect for improving constipation, much greater effects are shown when both components are used together.
  • liquid food refers not only to a food which is fluid in its ordinary state but also to a food having a potentially fluid character which can be easily converted to a liquid food such as pudding, jelly or ice cream when agitated or heated.
  • a food also includes a beverage.
  • Polydextrose R means water soluble polysaccharide having a molecular weight of 1500 ⁇ 18000 which is obtained by polymerizing glucose or maltose in a molten state using edible carboxylic acid, eg. citric acid, as a catalyst and crosslinking agent.
  • carboxylic acid eg. citric acid
  • the molecular chain of the polysaccharide is highly branched and hard to digest and the calorific content of it as a food is as low as 1 calorie per gram, heretofore it having been used as a low calory saccharic foodstuff.
  • polydextrose being different from oligosaccharides which are another component of the present invention that are hard to digest and easy to ferment, is difficult to be utilized even by intestinal bacteria.
  • the substance is being sold by Pfizer Inc. under the trade name of "Polydextrose”.
  • oligosaccharides which are hard to digest and easy to ferment, are difficult for digesting enzymes secreted from the human digestive tract to digest but they are easily utilized by intestinal bacteria.
  • the oligosaccharides of the invention are such fermentable substances that when mixed with four time diluted fresh human feces and kept in an anaerobic condition, more than 90 % would be diminished.
  • oligosaccharides include disaccharides, however, as most disaccharides are easy to digest and those disaccharides that are not easy to digest do not show significant effect when used together with polydextrose, disaccharides are excluded from the oligosaccharides of the present invention.
  • oligosaccharides for the present invention are those which can be utilized by bifidobacteria having a regulatory effect on intestine.
  • the oligosaccharides exemplified are: such raffinose family oligosaccharides which are made from soybean described in Japanese Patent Laid Open No.59-179064, galactose series oligosaccharides which are made from lactose described in Japanese Patent Publication No.58-20266, fructooligosaccharides described in Japanese Patent Publication No.59-53834, product of decomposition of Konjak mannan described in Japanese Patent Laid Open No.58-212780, levan (beta-2,6-fructan) described in Japanese Patent Laid Open No.57-18982, galactose series oligosaccharides which are made from lactose described in Japanese Patent Laid Open No.58-99497, partially hydrolyzed chitin described in Japanese Patent Laid
  • a liquid food of the present invention can be incorporated, apart from Polydextrose R and oligosaccharides which are hard to digest and easy to ferment, with other oligosaccharides which are hard to digest and are water soluble seasonings, flavors, and other appropriate materials in so far as they do not adversly affect the achievement of the present invention.
  • lactobacilli, streptococci, bifidobacteria or fermented milk containing them which have a regulatory effect on intestine preferable as subcomponents, since they are superior in view of their ingestive effect in the liquid food of the present invention.
  • both Polydextrose R and oligosaccharides are also effective in improving constipation. Although the mechanisms which affect said improvement are not clear, it is deemed that they both work in different ways due to their different fermenting abilities in the intestines, and when they are used together, significant effects much more superior to their being used alone can be shown. Since both materials are completely water soluble, they are suitable for making a liquid food having no solid residue and good texture.
  • the liquid food of the present invention achieves the object of improving constipation through the use of water soluble Polydextrose R and oligosaccharides, it has a taste and texture superior to those of conventional health foods which contain solid edible fibers. Moreover, since it is s stable liquid, it can be made in a variety of forms such as a beverage, fermented milk, jelly, ice cream etc., and can meet diversified consumers' tastes.
  • test group 1 polydextrose R 10 g/day test group 2: raffinose family oligosaccharides 3 g/day test group 3: polydextrose and 5 g/day faffinose family oligosaccharides 3 g/day
  • test group was dosed for 2 weeks. In order to avoid any influences from a preceeding test, a non dosage term of one week was set between each test group. Testing order for the groups was randomly changed according to subjects.
  • Table 1 shows the results of effect for improving constipation according to each test group, where a circle expresses that four or more than four items out of the five items tested had improved compared to before the dosage.
  • Table 2 shows the items which were judged as showing significantly increased scores according to "Student's t-test" for each item comparing the state before dosage and the result of the test.
  • constipation is cured after seeing an improvement in only one item. Therefore the indispensable requirements for judging whether constipation has been cured are as follows:
  • ice cream was made according to a conventional method: raw cream (45% formulated) 1000 g milk 450 Polydextrose R 75 55% fructo-oligosaccharides syrup* 118 sugar 100 egg yolks 200 flavor a few drops * produced by Meiji Seika KK, Bx 73.5
  • the product thus obtained was not any different from conventional ice cream in pleasant feeling to the palate.
  • coffee jelly was made according to a conventional method.
  • instant coffee powder 25 g Polydextrose R 100 50% galactose series oligosaccharides (the remaining 50% being unreacted materials and by-products composed mainly of galactose, glucose, lactose) 172 Sugar 75 water 1000 gelatine 25 * made by a method according to Japanese Patent Laid Open No.58-20266, Bx 70
  • the product thus obtained was not any different in texture from conventional coffee jelly.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Claims (6)

  1. Flüssignahrung zu Linderung von Verstopfung, dadurch gekennzeichnet, dass sie enthält
    (a) ein wasserlösliches Polysaccharid mit einem Molekulargewicht von 1500 bis 18000, das erhalten wird durch Polymerisation von Glucose oder Maltose in geschmolzenem Zustand unter Verwendung einer essbaren Carbonsäure als Katalysator und Vernetzungsmittel (PolydextroseR); und
    (b) ein wasserlösliches Oligosaccharidprodukt, verschieden von einem Disaccharid, welches im wesentlichen unverdaulich für menschliche Verdauungsenzyme, jedoch leicht fermentierbar durch Intestinalbakterien ist; wobei das Verhältnis von (a) zu (b) 1:10 bis 20:1 Gew.-Teile beträgt.
  2. Zuzammensetsung gemäss Anspruch 1, dadurch gekennzeichnet, dass das Oligosaccharid-Produkt (b) Oligosaccharide aus der Raffinose-Familie enthält, die von der Sojabohne stammen.
  3. Zusammensetzung gemäss Anspruch 1, dadurch gekennzeichnet, dass das Oligosaccharid-Produkt (b) Oligosaccharide aus der Galactosereihe umfasst, abgeleitet von Lactose durch die Wirkung von β-Galactosidase.
  4. Zusammensetzung gemäss Anspruch 1, dadurch gekennzeichnet, dass das Oligosaccharid-Produkt (b) ausgewählt ist aus:
    (i) Raffinose-Oligosacchariden, ausgewählt aus Raffinose und Stachyose;
    (ii) Oligosacchariden aus der Galactosereihe der Formel Gal-(Gal)m-Glc, worin m = 1, 2, 3 oder 4, oder Gal-(β-1,6)-Glc-(β-1,4)-Gal;
    (iii) Fructooligosacchariden der Formel Fru-(Fru)m-Glc, wobei m = 1, 2, 3 oder 4, oder Fru-(Fru)n-Glc-Fru, wobei n = 0 oder 1;
    (iv) Zersetzungsprodukten von Konjak-Mannan, das ein Oligosaccharid ist, das Glucose und Mannose umfasst;
    (v) Levan (β-2,6-Fructan);
    (vi) partiell hydrolysiertem Chitin der Formel Gal-(GlcNAc)m-Glc, wobei m = 1, 2, 3 oder 4; und
    (vii) Lactosucrose der Formel Gal-Glc-Fru, worin Gal = Galactoseeinheit; Glc = Glucoseeinheit; Fru = Fructoseeinheit; und GlcNAc = N-Acetylglucosamin-Einheit.
  5. Zusammensetzung gemäss einem der Ansprüche 1 bis 4, die in ihrem Normalzustand flüssig ist oder einen potentiell flüssigen Charakter hat, d.h. in eine Flüssigkeit umwandelbar ist, wenn sie gerührt oder erwärmt wird.
  6. Zusammensetzung gemäss Anspruch 5 in Form eines Getränkes.
EP87308205A 1986-03-18 1987-09-16 Flüssige Nahrungsmittel Expired - Lifetime EP0307523B1 (de)

Priority Applications (6)

Application Number Priority Date Filing Date Title
JP61058134A JPS62220169A (ja) 1986-03-18 1986-03-18 流動性食品
AU78155/87A AU624065B2 (en) 1987-09-08 1987-09-08 Liquid food
US07/096,483 US4859488A (en) 1987-09-15 1987-09-15 Liquid food for curing constipation: polydextrose and oligosaccharide
CA000546865A CA1324529C (en) 1987-09-15 1987-09-15 Liquid food comprising polydextrose and oligosaccharides
DE8787308205T DE3785035T2 (de) 1987-09-15 1987-09-16 Fluessige nahrungsmittel.
EP87308205A EP0307523B1 (de) 1987-09-15 1987-09-16 Flüssige Nahrungsmittel

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US07/096,483 US4859488A (en) 1987-09-15 1987-09-15 Liquid food for curing constipation: polydextrose and oligosaccharide
CA000546865A CA1324529C (en) 1987-09-15 1987-09-15 Liquid food comprising polydextrose and oligosaccharides
EP87308205A EP0307523B1 (de) 1987-09-15 1987-09-16 Flüssige Nahrungsmittel

Publications (2)

Publication Number Publication Date
EP0307523A1 EP0307523A1 (de) 1989-03-22
EP0307523B1 true EP0307523B1 (de) 1993-03-24

Family

ID=27167773

Family Applications (1)

Application Number Title Priority Date Filing Date
EP87308205A Expired - Lifetime EP0307523B1 (de) 1986-03-18 1987-09-16 Flüssige Nahrungsmittel

Country Status (4)

Country Link
US (1) US4859488A (de)
EP (1) EP0307523B1 (de)
CA (1) CA1324529C (de)
DE (1) DE3785035T2 (de)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7601364B2 (en) 1998-08-11 2009-10-13 N.V. Nutricia Carbohydrate mixtures
US8252769B2 (en) 2004-06-22 2012-08-28 N. V. Nutricia Intestinal barrier integrity
US10426791B2 (en) 2004-05-17 2019-10-01 N.V. Nutricia Synergism of GOS and polyfructose

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988008257A1 (fr) * 1987-04-25 1988-11-03 Terumo Kabushiki Kaisha Aliment facilitant l'activite intestinale
US5219573A (en) * 1989-10-17 1993-06-15 Hershey Foods Corporation L-sugar laxatives
JP2729406B2 (ja) * 1989-12-27 1998-03-18 松谷化学工業株式会社 難消化性ヘテロ多糖類の製造法
US5659028A (en) * 1990-02-23 1997-08-19 Raffinerie Tirlemontoise S.A. Branched fructo-oligosaccharides, method for obtaining them and use of products containing them
KR0161531B1 (ko) * 1990-03-08 1998-11-16 하야시바라 겐 락토수크로오스 고함유 분말의 제조방법과 그 분말의 용도
US6162484A (en) * 1990-07-23 2000-12-19 T. W. Burleson & Son Method for the production of a reduced calorie honey composition
JP2834871B2 (ja) * 1990-08-07 1998-12-14 塩水港精糖株式会社 フラクトース含有オリゴ糖の製造法
US5294458A (en) * 1992-04-03 1994-03-15 Maruha Corporation Pet food
DE69118211T2 (de) * 1991-08-07 1996-10-02 Raffinerie Tirlemontoise Sa Kalorienarme schokolade-zusammensetzung
JP2571734B2 (ja) * 1991-08-23 1997-01-16 株式会社ヤクルト本社 乳酸菌飲料
CA2050464C (en) * 1991-08-30 1997-12-16 Tsutomu Harada Food containing fructose
DE69312851T2 (de) * 1992-04-10 1998-01-08 Otsuka Pharmaceutical Co., Ltd., Tokio/Tokyo Nahrungsmittelzusammensetzung zur hemmung von der bildung von darmverrottungsprodukten
US5849324A (en) * 1995-07-10 1998-12-15 Abbott Laboratories Use of indigestible oligosaccharides to reduce the incidence of otitis media in humans
US5827526A (en) * 1995-07-11 1998-10-27 Abbott Laboratories Use of indigestible oligosaccharides to prevent gastrointestinal infections and reduce duration of diarrhea in humans
FR2750298B1 (fr) * 1996-07-01 1998-09-18 Gefa Composition en poudre pour la preparation d'un aliment a base de yaourt
BR9711054B1 (pt) * 1996-08-09 2011-10-18 composição de suplemento dietético para fornecer sacarìdeos de produtos nutritivos.
US6929807B1 (en) * 1996-08-09 2005-08-16 Mannatech, Inc. Compositions of plant carbohydrates as dietary supplements
DE69600525T2 (de) * 1996-12-23 1998-12-10 Sitia-Yomo S.P.A., Mailand/Milano Lyophilisierte, lebende Bakerien enthaltende Nahrungszusammensetzung
ATE323421T1 (de) * 1997-07-05 2006-05-15 Nestle Sa Gefrorenes dessert, welches milchsäurebakterien und fermentierbare ballaststoffe enthält
DE19958985A1 (de) * 1999-12-07 2001-06-13 Nutricia Nv Oligosaccharidmischung
DE10008279A1 (de) * 2000-02-23 2001-08-30 Meggle Gmbh Milchzucker enthaltende Zusammensetzung
AU2003266367A1 (en) * 2002-09-10 2004-04-30 Nestec S.A. Water beverage containing fibres
EP1629730A1 (de) * 2004-08-12 2006-03-01 First-to-Market N.V. Funktioneller Zuckerersatz
MX2007013725A (es) 2005-05-05 2008-04-09 Sensient Flavors Inc Produccion de beta-glucanos y mananos.
US7572474B2 (en) * 2005-06-01 2009-08-11 Mead Johnson Nutrition Company Method for simulating the functional attributes of human milk oligosaccharides in formula-fed infants
KR101342311B1 (ko) * 2005-06-24 2013-12-16 카오카부시키가이샤 야채 및/또는 과실 음료 조성물
US8287931B2 (en) * 2005-06-30 2012-10-16 Mead Johnson Nutrition Company Nutritional composition to promote healthy development and growth
US8075934B2 (en) * 2008-10-24 2011-12-13 Mead Johnson Nutrition Company Nutritional composition with improved digestibility
EP1946645B1 (de) * 2005-11-11 2012-05-23 Kabushiki Kaisha Yakult Honsha Sauermilchgetränk und verfahren zu seiner herstellung
US8729051B2 (en) 2006-05-30 2014-05-20 Nutrition Sciences N.V./S.A. Tri- and tetra-oligo-saccharides suitable as agglutination agents for enteric pathogens
US8986769B2 (en) * 2008-10-24 2015-03-24 Mead Johnson Nutrition Company Methods for preserving endogenous TGF-β
US8425955B2 (en) * 2009-02-12 2013-04-23 Mead Johnson Nutrition Company Nutritional composition with prebiotic component
US8293264B2 (en) * 2009-05-11 2012-10-23 Mead Johnson Nutrition Company Nutritional composition to promote healthy development and growth
BR112013010783A2 (pt) 2010-11-11 2016-07-12 Nestec Sa confecções congeladas contendo micro-organismos probióticos
CN108014127A (zh) * 2016-11-01 2018-05-11 北京圣传创世科技发展有限公司 一种药物组合物
CN108014128A (zh) * 2016-11-01 2018-05-11 北京圣传创世科技发展有限公司 一种药物组合物

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3766165A (en) * 1966-08-17 1973-10-16 Pfizer Polysaccharides and their preparation
US4024290A (en) * 1976-03-22 1977-05-17 G. D. Searle & Co. Bulking agent for foods
JPS55118369A (en) * 1979-03-06 1980-09-11 Hayashibara Biochem Lab Inc Method of making beverage and food
US4435389A (en) * 1980-07-07 1984-03-06 Kabushiki Kaisha Yakult Honsha Composition for promoting growth of bifidobacteria
JPS5718982A (en) * 1980-07-11 1982-01-30 Dai Ichi Seiyaku Co Ltd Growth promotor for lactobacillus bifidus
JPS5899497A (ja) * 1981-11-27 1983-06-13 Snow Brand Milk Prod Co Ltd 新規なオリゴ糖、その製造法及びビフイドバクテリウム菌の増殖促進剤
JPS5899498A (ja) * 1981-12-04 1983-06-13 Dai Ichi Seiyaku Co Ltd フラボノ−ル配糖体
GB2116820B (en) * 1982-03-16 1985-10-16 Cumberland Packing Corp Sweetener compositions
JPS5953834B2 (ja) * 1982-05-19 1984-12-27 明治製菓株式会社 ビフイズス菌増殖促進物質
JPS58212780A (ja) * 1982-06-07 1983-12-10 Yakult Honsha Co Ltd ビフイドバクテリウム菌の増殖促進物質
JPS5911190A (ja) * 1982-07-07 1984-01-20 Snow Brand Milk Prod Co Ltd 新規なオリゴ糖、その製造法及びオリゴ糖を活性成分とするビフイドバクテリウム菌の増殖促進剤
JPS5953835B2 (ja) * 1982-08-31 1984-12-27 ビオフェルミン製薬株式会社 ビフイズス菌用選択的糖源
JPS5953835A (ja) * 1982-09-22 1984-03-28 Nippon Oil & Fats Co Ltd 水溶性光硬化性樹脂組成物
JPS59173062A (ja) * 1983-03-19 1984-09-29 Riboseren:Kk 保健食品とその製造法
JPS59179064A (ja) * 1983-03-30 1984-10-11 Yakult Honsha Co Ltd ビフイドバクテリウム菌増殖促進物質の製造法
FR2547167B1 (fr) * 1983-06-10 1985-08-30 Loucanov Ignat Nouvel aliment dietetique
US4690827A (en) * 1985-07-31 1987-09-01 The Procter & Gamble Company Fruit juice containing diet beverage

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7601364B2 (en) 1998-08-11 2009-10-13 N.V. Nutricia Carbohydrate mixtures
US8277836B2 (en) 1998-08-11 2012-10-02 N.V. Nutricia Carbohydrates mixture
US8580295B2 (en) 1998-08-11 2013-11-12 N.V. Nutricia Carbohydrates mixture
US9763466B2 (en) 1998-08-11 2017-09-19 N.V. Nutricia Carbohydrates mixture
US10426791B2 (en) 2004-05-17 2019-10-01 N.V. Nutricia Synergism of GOS and polyfructose
US9084433B2 (en) 2004-06-06 2015-07-21 N. V. Nutricia Intestinal barrier integrity
US10499676B2 (en) 2004-06-06 2019-12-10 N.V. Nutricia Intestinal barrier integrity
US8252769B2 (en) 2004-06-22 2012-08-28 N. V. Nutricia Intestinal barrier integrity
US11076623B2 (en) 2004-06-22 2021-08-03 N.V. Nutricia Intestinal barrier integrity

Also Published As

Publication number Publication date
US4859488A (en) 1989-08-22
EP0307523A1 (de) 1989-03-22
DE3785035D1 (de) 1993-04-29
DE3785035T2 (de) 1993-07-01
CA1324529C (en) 1993-11-23

Similar Documents

Publication Publication Date Title
US4859488A (en) Liquid food for curing constipation: polydextrose and oligosaccharide
CN111542593B (zh) 新型双歧杆菌属细菌和包含该细菌的组合物
US7141554B2 (en) Method of treating irritable bowel syndrome
AU2003245923B2 (en) Galactosyl isomalt, method for production and use thereof
JP7516053B2 (ja) 組成物並びに飲食品組成物、栄養組成物および調製乳
CN1802101B (zh) 异麦芽酮糖醇(1,6gps和1,1gpm混合物)作为生产用于治疗肠道疾病的药物及其他用途的益生元的应用
US7101553B2 (en) Immune response enhancement methods
Moynihan Update on the nomenclature of carbohydrates and their dental effects
US5698437A (en) Agent for promoting the proliferation of bifidobacterium
JP2002502356A (ja) 下痢の予防及び治療への非消化性オリゴ糖の使用
US20190298783A1 (en) Composition for relieving stress, pharmaceutical composition and food and drink composition and method for relieving stress using the composition for relieving stress
CN102578228A (zh) 一种无糖谷物酸奶
AU719547B2 (en) Use of indigestible oligosaccharides to treat and prevent otitis media in humans
WO2019112053A1 (ja) 新規ビフィドバクテリウム属細菌及び当該細菌を含む組成物
JP2816726B2 (ja) 腸内環境改善用組成物
CN114403403B (zh) 一种具有减脂减重功效的果冻及其制备方法
JPH0342876B2 (de)
JP4336930B2 (ja) 乳酸菌発酵液の製造方法及び該発酵液を原料とする食品
KR102685690B1 (ko) 유산균 식혜의 제조방법 및 이에 따라 제조된 유산균 식혜
JP2015514411A (ja) β−グルカンとアラビノキシランとの組合せ物
AU624065B2 (en) Liquid food
KR920002004B1 (ko) 유동성 식품의 제조방법
EP1290952B1 (de) Mit ballaststoffen angereicherte zusammensetzungen
CN110934187A (zh) 一种低糖铁皮石斛保健酸奶及其制备方法
NZ221787A (en) Liquid food containing polydextrose and oligosaccharides

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19880830

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): CH DE FR GB IT LI NL SE

17Q First examination report despatched

Effective date: 19900628

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): CH DE FR GB IT LI NL SE

ITF It: translation for a ep patent filed
REF Corresponds to:

Ref document number: 3785035

Country of ref document: DE

Date of ref document: 19930429

ET Fr: translation filed
PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed
EAL Se: european patent in force in sweden

Ref document number: 87308205.1

REG Reference to a national code

Ref country code: GB

Ref legal event code: IF02

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: NL

Payment date: 20040905

Year of fee payment: 18

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: SE

Payment date: 20040906

Year of fee payment: 18

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20040908

Year of fee payment: 18

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20040909

Year of fee payment: 18

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20040915

Year of fee payment: 18

Ref country code: CH

Payment date: 20040915

Year of fee payment: 18

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES;WARNING: LAPSES OF ITALIAN PATENTS WITH EFFECTIVE DATE BEFORE 2007 MAY HAVE OCCURRED AT ANY TIME BEFORE 2007. THE CORRECT EFFECTIVE DATE MAY BE DIFFERENT FROM THE ONE RECORDED.

Effective date: 20050916

Ref country code: GB

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20050916

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20050917

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20050930

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20050930

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NL

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20060401

Ref country code: DE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20060401

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

EUG Se: european patent has lapsed
GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 20050916

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20060531

NLV4 Nl: lapsed or anulled due to non-payment of the annual fee

Effective date: 20060401

REG Reference to a national code

Ref country code: FR

Ref legal event code: ST

Effective date: 20060531